GALNT7 and cervical carcinoma: MiR‐125a‐5p, for example, inhibits cervical cancer cell proliferation both in vivo and in vitro by targeting GALNT7 to inhibit the signaling cascade EGFR/PI3K/AKT after significantly down‐regulating such miRNA in cervical cancer cells.30